The objective of many high-dimensional microarray and RNA-seq studies is to develop a classifier of cancer patients based on characteristics of their disease. The germinal center B-cell (GCB) ...

Vancouver, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global microarray analysis market size was USD 4.90 Billion in 2022 and is expected to register a rapid revenue CAGR of 9.0% during the forecast period ...

We have assessed the utility of RNA titration samples for evaluating microarray platform performance and the impact of different normalization methods on the results obtained. As part of the ...